Rectal cancer

Maria Giulia Zampino; Roberto Labianca; Giordano D. Beretta; Elena Magni; Gemma Gatta; Maria Cristina Leonardi; Antonio Chiappa; Roberto Biffi; Filippo de Braud; Jacques Wils

doi:10.1016/j.critrevonc.2008.10.010

Rectal cancer

Maria Giulia Zampino, Roberto Labianca, Giordano D. Beretta, Elena Magni, Gemma Gatta, Maria Cristina Leonardi, Antonio Chiappa, Roberto Biffi, Filippo de Braud, Jacques Wils

Research output: Contribution to journal › Article

Abstract

Rectal cancer is an important tumour from an epidemiological point of view and represents the benchmark for an optimal use of integrated treatments (surgery, radiotherapy and chemotherapy) in the oncological practice. The conventional use of total mesorectal excision and the integration with radiochemotherapy, better if preoperatively, are now able to increase survival, to decrease the occurrence of pelvic recurrence and to ameliorate the quality of life of patients. Updated recommendations for the management of these patients are here reported.

Original language	English
Pages (from-to)	160-182
Number of pages	23
Journal	Critical Reviews in Oncology/Hematology
Volume	70
Issue number	2
DOIs	https://doi.org/10.1016/j.critrevonc.2008.10.010
Publication status	Published - May 2009

Keywords

Rectal cancer
Strategy
Treatment

ASJC Scopus subject areas

Oncology
Hematology
Geriatrics and Gerontology

Access to Document

10.1016/j.critrevonc.2008.10.010

Fingerprint Dive into the research topics of 'Rectal cancer'. Together they form a unique fingerprint.

Cite this

Zampino, M. G., Labianca, R., Beretta, G. D., Magni, E., Gatta, G., Leonardi, M. C., Chiappa, A., Biffi, R., de Braud, F., & Wils, J. (2009). Rectal cancer. Critical Reviews in Oncology/Hematology, 70(2), 160-182. https://doi.org/10.1016/j.critrevonc.2008.10.010

@article{a7fc8563c4d941e5a97840c6f42b6c2a,

title = "Rectal cancer",

abstract = "Rectal cancer is an important tumour from an epidemiological point of view and represents the benchmark for an optimal use of integrated treatments (surgery, radiotherapy and chemotherapy) in the oncological practice. The conventional use of total mesorectal excision and the integration with radiochemotherapy, better if preoperatively, are now able to increase survival, to decrease the occurrence of pelvic recurrence and to ameliorate the quality of life of patients. Updated recommendations for the management of these patients are here reported.",

keywords = "Rectal cancer, Strategy, Treatment",

author = "Zampino, {Maria Giulia} and Roberto Labianca and Beretta, {Giordano D.} and Elena Magni and Gemma Gatta and Leonardi, {Maria Cristina} and Antonio Chiappa and Roberto Biffi and {de Braud}, Filippo and Jacques Wils",

year = "2009",

month = may,

doi = "10.1016/j.critrevonc.2008.10.010",

language = "English",

volume = "70",

pages = "160--182",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - Rectal cancer

AU - Zampino, Maria Giulia

AU - Labianca, Roberto

AU - Beretta, Giordano D.

AU - Magni, Elena

AU - Gatta, Gemma

AU - Leonardi, Maria Cristina

AU - Chiappa, Antonio

AU - Biffi, Roberto

AU - de Braud, Filippo

AU - Wils, Jacques

PY - 2009/5

Y1 - 2009/5

N2 - Rectal cancer is an important tumour from an epidemiological point of view and represents the benchmark for an optimal use of integrated treatments (surgery, radiotherapy and chemotherapy) in the oncological practice. The conventional use of total mesorectal excision and the integration with radiochemotherapy, better if preoperatively, are now able to increase survival, to decrease the occurrence of pelvic recurrence and to ameliorate the quality of life of patients. Updated recommendations for the management of these patients are here reported.

AB - Rectal cancer is an important tumour from an epidemiological point of view and represents the benchmark for an optimal use of integrated treatments (surgery, radiotherapy and chemotherapy) in the oncological practice. The conventional use of total mesorectal excision and the integration with radiochemotherapy, better if preoperatively, are now able to increase survival, to decrease the occurrence of pelvic recurrence and to ameliorate the quality of life of patients. Updated recommendations for the management of these patients are here reported.

KW - Rectal cancer

KW - Strategy

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=63549127178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63549127178&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2008.10.010

DO - 10.1016/j.critrevonc.2008.10.010

M3 - Article

C2 - 19059790

AN - SCOPUS:63549127178

VL - 70

SP - 160

EP - 182

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 2

ER -